Antonia Zonno

T cells support osteoclastogenesis in an in vitro model derived from human multiple myeloma bone disease: the role of the OPG/TRAIL interaction

Silvia Colucci, Giacomina Brunetti, Rita Rizzi et al. · Blood · 2004 · 147 citations · Full text

Medicine, Cell Biology, Immunology +16

Response to recombinant erythropoietin alpha, without the adjunct of granulocyte-colony stimulating factor, is associated with a longer survival in patients with transfusion-dependent myelodysplastic syndromes

Pellegrino Musto, Oreste Villani, Maria Carmen Martorelli et al. · Leukemia Research · 2009 · 29 citations

Medicine, Hematology, Immunology +12

Addition of Niraparib to Best Supportive Care as Maintenance Treatment in Patients with Advanced Urothelial Carcinoma Whose Disease Did Not Progress After First-line Platinum-based Chemotherapy: The Meet-URO12 Randomized Phase 2 Trial

Francesca Vignani, Rosa Tambaro, Ugo De Giorgi et al. · European Urology · 2022 · 22 citations

Medicine, Oncology, Pharmacology +13

Randomized phase II study of niraparib plus best supportive care (BSC) versus BSC alone as maintenance treatment in patients with advanced urothelial carcinoma (UC) whose disease did not progress after first-line platinum-based chemotherapy (PBCT): The Meet-URO12 trial.

Francesca Vignani, Rosa Tambaro, Ugo De Giorgi et al. · Journal of Clinical Oncology · 2022 · 13 citations

Medicine, Oncology, Pharmacotherapy +16

Final Results of a Phase II Study Evaluating Lenalidomide in Combination with Low Dose Dexamethasone As First Line Therapy for Primary Plasma Cell Leukemia

Pellegrino Musto, Fiorella D’Auria, Maria Teresa Petrucci et al. · Blood · 2011 · 12 citations

Medicine, Oncology, Pharmacotherapy +10